iSERA Lifesciences has received approval from Board of Directors for acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological, an unlisted public company, comprising up to 1,61,82,800 equity shares of face value Rs 10 each, from the existing shareholders of iSERA Biological, for a total consideration of Rs 78,00,10,960. Upon completion of the said acquisition, iSERA Biological shall become a wholly owned subsidiary of iSERA Lifesciences.
iSERA Lifesciences (Formerly known as Covidh Technologies) is a technology services provider with an established footprint across diverse domains.
| Company Name | CMP |
|---|---|
| TCS | 2162.35 |
| Infosys | 1084.05 |
| HCL Technologies | 1201.00 |
| Wipro | 177.25 |
| Tech Mahindra | 1494.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: